85fe3bff03a1df9d…

{
  "id": "NCT00017940",
  "type": "Study",
  "data": {
    "briefSummary": "This Phase I clinical trial is the first step in testing gene therapy. This study is called a \"Safety/Toxicity\" study by the Food and Drug Administration, and primarily aims to determine whether the experimental protocol is safe for humans. It will determine whether the study procedure causes side effects in humans, and may also give us a preliminary sense of whether this will be effective in combating Alzheimer's disease in humans.",
    "completionDate": "2003-11",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": 8,
    "enrollmentType": null,
    "nctId": "NCT00017940",
    "phase": "PHASE1",
    "sponsorId": "the-shiley-family-trust",
    "startDate": null,
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "A Phase I Study of Ex Vivo Nerve Growth Factor Gene Therapy for Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00017940"
  }
}